Oxaprozin
- Product NDC
- 60760-092
- 11-digit product format
- 607600092
- Labeler code
- 60760
- Product ID
- 60760-092_90b7ce00-cc37-3cd0-e053-2995a90a2c19
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxaprozin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St Mary's Medical Park Pharmacy
- Application
- ANDA208633
- Marketing category
- ANDA
- Marketing start
- 2019-08-21
- Marketing end
- 0000-00-00
- Substance
- OXAPROZIN
- Active strength
- 600 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-092-14 | 60760009214 | 14 TABLET in 1 BOTTLE, PLASTIC (60760-092-14) | 14 tablet | 2019-08-21 | 0000-00-00 | No | No | Current |